158 related articles for article (PubMed ID: 31757995)
1. 2, 3-Dihydro-3β-methoxy Withaferin-A Lacks Anti-Metastasis Potency: Bioinformatics and Experimental Evidences.
Chaudhary A; Kalra RS; Malik V; Katiyar SP; Sundar D; Kaul SC; Wadhwa R
Sci Rep; 2019 Nov; 9(1):17344. PubMed ID: 31757995
[TBL] [Abstract][Full Text] [Related]
2. 2,3-Dihydro-3β-methoxy Withaferin-A Protects Normal Cells against Stress: Molecular Evidence of Its Potent Cytoprotective Activity.
Chaudhary A; Kalra RS; Huang C; Prakash J; Kaul SC; Wadhwa R
J Nat Prod; 2017 Oct; 80(10):2756-2760. PubMed ID: 29043807
[TBL] [Abstract][Full Text] [Related]
3. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
[TBL] [Abstract][Full Text] [Related]
4. Withanone-rich combination of Ashwagandha withanolides restricts metastasis and angiogenesis through hnRNP-K.
Gao R; Shah N; Lee JS; Katiyar SP; Li L; Oh E; Sundar D; Yun CO; Wadhwa R; Kaul SC
Mol Cancer Ther; 2014 Dec; 13(12):2930-40. PubMed ID: 25236891
[TBL] [Abstract][Full Text] [Related]
5. Withanolide Derivative 2,3-Dihydro-3β-methoxy Withaferin-A Modulates the Circadian Clock via Interaction with RAR-Related Orphan Receptor α (RORa).
Tomita T; Wadhwa R; Kaul SC; Kurita R; Kojima N; Onishi Y
J Nat Prod; 2021 Jul; 84(7):1882-1888. PubMed ID: 34152143
[TBL] [Abstract][Full Text] [Related]
6. Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera.
Joshi P; Misra L; Siddique AA; Srivastava M; Kumar S; Darokar MP
Steroids; 2014 Jan; 79():19-27. PubMed ID: 24184562
[TBL] [Abstract][Full Text] [Related]
7. Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone.
Malik V; Radhakrishnan N; Kaul SC; Wadhwa R; Sundar D
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204712
[TBL] [Abstract][Full Text] [Related]
8. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
9. Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost.
Kaur A; Singh B; Ohri P; Wang J; Wadhwa R; Kaul SC; Pati PK; Kaur A
PLoS One; 2018; 13(4):e0194314. PubMed ID: 29659590
[TBL] [Abstract][Full Text] [Related]
10. Effect of Ashwagandha Withanolides on Muscle Cell Differentiation.
Wang J; Zhang H; Kaul A; Li K; Priyandoko D; Kaul SC; Wadhwa R
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680087
[No Abstract] [Full Text] [Related]
11. Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.
Yu Y; Katiyar SP; Sundar D; Kaul Z; Miyako E; Zhang Z; Kaul SC; Reddel RR; Wadhwa R
Cell Death Dis; 2017 Apr; 8(4):e2755. PubMed ID: 28425984
[TBL] [Abstract][Full Text] [Related]
12. Wild type p53 function in p53
Sundar D; Yu Y; Katiyar SP; Putri JF; Dhanjal JK; Wang J; Sari AN; Kolettas E; Kaul SC; Wadhwa R
J Exp Clin Cancer Res; 2019 Feb; 38(1):103. PubMed ID: 30808373
[TBL] [Abstract][Full Text] [Related]
13. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer.
Yadav DK; Kumar S; Saloni ; Singh H; Kim MH; Sharma P; Misra S; Khan F
Drug Des Devel Ther; 2017; 11():1859-1870. PubMed ID: 28694686
[TBL] [Abstract][Full Text] [Related]
15. Molecular Insights Into Withaferin-A-Induced Senescence: Bioinformatics and Experimental Evidence to the Role of NFκB and CARF.
Bhargava P; Malik V; Liu Y; Ryu J; Kaul SC; Sundar D; Wadhwa R
J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(2):183-191. PubMed ID: 29718136
[TBL] [Abstract][Full Text] [Related]
16. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
[TBL] [Abstract][Full Text] [Related]
17. Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action.
Sari AN; Bhargava P; Dhanjal JK; Putri JF; Radhakrishnan N; Shefrin S; Ishida Y; Terao K; Sundar D; Kaul SC; Wadhwa R
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380701
[TBL] [Abstract][Full Text] [Related]
18. Anti-cancer activity of withaferin A in B-cell lymphoma.
McKenna MK; Gachuki BW; Alhakeem SS; Oben KN; Rangnekar VM; Gupta RC; Bondada S
Cancer Biol Ther; 2015; 16(7):1088-98. PubMed ID: 26020511
[TBL] [Abstract][Full Text] [Related]
19. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
[TBL] [Abstract][Full Text] [Related]
20. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A.
Vadloori B; Sharath AK; Prabhu NP; Maurya R
BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
